基于风险选择的多点活检阴道镜检查提高宫颈癌前病变检出率的前瞻性研究
该前瞻性研究纳入690名因宫颈癌筛查异常转诊阴道镜的18-67岁女性,基于细胞学、HPV基因分型和阴道镜印象建立24个风险分层,评估多点活检的增量获益。结果显示各层癌前病变检出风险为2%-82%,最高风险层风险与即刻治疗相当,多点活检在多数风险层显著提高检出率。
要点
- 基于阴道镜印象、细胞学和HPV基因分型的24层风险分层中,癌前病变检出风险范围为2%-82%。
- 最高风险层癌前病变风险与即刻治疗水平一致,最低风险层多点活检仅边际增加检出。
- 多点活检方案未检出癌前病变者随访期间癌前病变风险低。
核心结论
- 阴道镜检查时的风险评估使宫颈癌前病变的识别更有效和高效。
- 多点活检方案未发现癌前病变可提供高度 reassurance,允许女性返回常规筛查。
研究设计与样本
- 前瞻性研究,纳入690名18-67岁因宫颈癌筛查异常转诊阴道镜的女性(ClinicalTrials.gov: NCT00339989)。
- 阴道镜检查时取最多4处宫颈活检以评估多点活检的增量获益。
- 使用宫颈细胞学、HPV基因分型和阴道镜印象建立最多24个风险分层。
- 主要分析结局为阴道镜引导活检检出的宫颈癌前病变(p16+宫颈上皮内瘤变2级及所有宫颈上皮内瘤变3级)。
主要发现
- 基于阴道镜印象、细胞学和HPV基因分型的24个分层中,癌前病变检出风险范围为2%-82%。
- 最低风险层中多点活检仅边际增加癌前病变风险。
- 最高风险层女性癌前病变风险与即刻治疗一致。
- 其他风险层中多点活检显著提高宫颈癌前病变检出。
- 361名基线宫颈上皮内瘤变<2级女性中,195名(54%)有随访细胞学或组织学数据,中位随访时间508天。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sensitivity for detection of precancers at colposcopy and reassurance provided by a negative colposcopy are in need of systematic study and improvement. OBJECTIVE: We sought to evaluate whether selecting the appropriate women for multiple targeted cervical biopsies based on screening cytology, human papillomavirus testing, and colposcopic impression could improve accuracy and efficiency of cervical precancer detection. STUDY DESIGN: In all, 690 women aged 18-67 years referred to colposcopy subsequent to abnormal cervical cancer screening results were included in the study (ClinicalTrials.gov: NCT00339989). Up to 4 cervical biopsies were taken during colposcopy to evaluate the incremental benefit of multiple biopsies. Cervical cytology, human papillomavirus genotyping, and colposcopy impression were used to establish up to 24 different risk strata. Outcomes for the primary analysis were cervical precancers, which included p16+ cervical intraepithelial neoplasia 2 and all cervical intraepithelial neoplasia 3 that were detected by colposcopy-guided biopsy during the colposcopy visit. Later outcomes in women without cervical intraepithelial neoplasia 2+ at baseline were abstracted from electronic medical records. RESULTS: The risk of detecting precancer ranged from 2-82% across 24 strata based on colposcopy impression, cytology, and human papillomavirus genotyping. The risk of precancer in the lowest stratum increased only marginally with multiple biopsies. Women in the highest-risk strata had risks of precancer consistent with immediate treatment. In other risk strata, multiple biopsies substantially improved detection of cervical precancer. Among 361 women with cervical intraepithelial neoplasia <2 at baseline, 195 (54%) had follow-up cytology or histology data with a median follow-up time of 508 days. Lack of detection of precancer at initial colposcopy that included multiple biopsies predicted low risk of precancer during follow-up. CONCLUSION: Risk assessment at the colposcopy visit makes identification of cervical precancers more effective and efficient. Not finding precancer after a multiple-biopsy protocol provides high reassurance and allows releasing women back to regular screening.
引用
- Wentzensen N, Walker J, Smith K, et al. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol. 2018. PMID: 29462629. doi:10.1016/j.ajog.2018.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。